CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

FierceBiotech
Original article

{"a":[{"_":"Psilocybin proves promising in neuropathic pain mouse study","$":{"href":"/research/psilocybin-proves-promising-neuropathic-pain-study-mice","hreflang":"en"}}]}

Data ReadoutpositivePsilocybinPositive
AI Analysis

Summary

Researchers have demonstrated that psilocybin shows promise as a potential treatment for chemotherapy-induced peripheral neuropathy in a mouse study. This preclinical finding adds to growing research into psychedelics for medical applications.

Clinical Trial Data

Outcome Details

Psilocybin proved promising in neuropathic pain mouse study

Importance:2/10
Sentiment:
0.60
psychedelicspsilocybinneuropathic painchemotherapy-induced peripheral neuropathypreclinicalmouse study

Read the original article

Published by FierceBiotech on September 3, 2026 11:58 AM

Read Original